Cypherpunk Technologies (NASDAQ:CYPH) Stock Crosses Below Fifty Day Moving Average - Here's What Happened

Key Points

• Cypherpunk Technologies shares fell below their 50-day moving average, trading as low as $0.6635 before last changing hands at $0.68. The stock’s 50-day average is $0.69, compared with a 200-day average of $0.78.
• Analyst views are mixed, with ratings ranging from Strong Buy to Sell, but the consensus rating is Moderate Buy and the average price target is $0.90.
• The company reported a quarterly loss of $0.46 per share, missing the $0.04 loss analysts expected. Institutional investors own 30.46% of the company, while Cypherpunk continues developing cancer therapies and pursuing a Zcash-focused digital-asset treasury strategy.

Shares of Cypherpunk Technologies (NASDAQ:CYPH - Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.69 and traded as low as $0.6635. Cypherpunk Technologies shares last traded at $0.68, with a volume of 801,697 shares.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Wall Street Zen upgraded Cypherpunk Technologies from a "sell" rating to a "hold" rating in a report on Saturday, July 4th. Weiss Ratings cut Cypherpunk Technologies from a "sell (d-)" rating to a "sell (e+)" rating in a report on Friday, July 31st. Finally, Cantor Fitzgerald upgraded shares of Cypherpunk Technologies to a "strong-buy" rating in a research report on Friday, July 3rd. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Cypherpunk Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $0.90.

Cypherpunk Technologies Stock Up 0.0%

The business has a fifty day moving average of $0.69 and a 200 day moving average of $0.78. The firm has a market cap of $72.39 million, a P/E ratio of -33.98 and a beta of 0.09.

Cypherpunk Technologies (NASDAQ:CYPH - Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.42).

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Millennium Management LLC acquired a new stake in Cypherpunk Technologies in the fourth quarter worth $37,000. LPL Financial LLC bought a new stake in shares of Cypherpunk Technologies in the 4th quarter valued at $38,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Cypherpunk Technologies in the 4th quarter valued at $44,000. Sequoia Financial Advisors LLC bought a new position in Cypherpunk Technologies during the fourth quarter worth about $56,000. Finally, HighTower Advisors LLC bought a new position in Cypherpunk Technologies during the fourth quarter worth about $59,000. Institutional investors and hedge funds own 30.46% of the company's stock.

About Cypherpunk Technologies

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source